Saquinavir and ritonavir: Arrhythmia risks
Links shared publicly online about this topic.
- 1,360total visits
Saquinavir and ritonavir: Arrhythmia risks
View full resource at theheart.org
Tags: Heart Block, HIV, HIV Medication, STD, Drug, FDA, Norvir, Invirase
Most Recently Shared on February 23, 2010 at 8:11 pm By:
FDA warning: HIV drug combo and rhythm disturbances: Preliminary data suggest that the combination of saquinavir a... http://bit.ly/axM79Z
European Medicines Agency Concludes That Benefit-risk Balance Of Invirase Remains Positive
medicalnewstoday.com — “The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has reviewed all available data on Invirase (saquinavir) and the potential risk of arrhythmia, and concluded t” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2010 at 10:24 am By:
MedicalNewsToday: European Medicines Agency Concludes That Benefit-risk Balance Of Invirase: http://bit.ly/95ph0o Full http://bit.ly/ctj2iu
HIV Drug Combination Invirase Plus Norvir Can Cause Life Threatening Heart Problems
medicalnewstoday.com — “HIV antiviral medication Invirase (saquinavir) when taken in combination with Norvir (ritonavir), also an HIV antiviral, can increase the risk of life-threatening heart rhythm abnormalities, trigg” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 9:08 pm By:
HIV Drug Combination Invirase Plus Norvir Can Cause Life Threatening Heart Problems: HIV antiviral medication Invi... http://mnt.to/f/3LDP
Invirase labeling updated to include cardiac risk with Norvir - MPR
empr.com — “The FDA announced that new safety information has been added to the label for Invirase (saquinavir, from Genentech), describing potentially life-threatening cardiac effects when used with Norvir (ritonavir, from Abbott).” View full resource at empr.com
Most Recently Shared on October 21, 2010 at 9:06 pm By:
MPR News: Invirase labeling updated to include cardiac risk with Norvir: The FDA announced that new safety informa... http://bit.ly/9u5okh
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
fda.gov — “Prolonged QT or PR intervals reported when Invirase is used with the antiviral medication, Norvir (ritonavir).” View full resource at fda.gov
Most Recently Shared on October 21, 2010 at 7:58 pm By:
Trish D'Antonio Health Professional
Getting the word out: FDA: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm (http://bit.ly/9sMymg)
Invirase labeling updated to include cardiac risk with Norvir - ONA
oncologynurseadvisor.com — “The FDA announced that new safety information has been added to the label for Invirase (saquinavir, from Genentech), describing potentially life-threatening cardiac effects when used with Norvir (ritonavir, from Abbott).” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 21, 2010 at 7:21 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Invirase labeling updated to include cardiac risk with Norvir http://goo.gl/fb/3HTNM
Symposier - Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA is reviewing clinical trial data suggesting that using Invirase (saquinavir) in combination with Norvir (ritonavir) may increase the risk of cardiac arrhythmias. Invirase and Norvir are protease inhibitors used in combination to treat HIV infection. The study was conducted by Roche, the manufacturer of Invirase, in response to FDA's request that all manufacturers of protease inhibitors evaluate the effect of these drugs on QT and PR ” View full resource at symposier.com
Most Recently Shared on May 24, 2010 at 10:17 pm By:
Symposier Cardiology Cardiology and Health Business
Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias. http://bit.ly/9rZAqS
FDA reviews cardiac risk of Invirase in combination with Norvir - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals and patients that it is reviewing clinical trial data about a potentially serious effect on the heart associated with the use of Invirase (saquinavir, from Roche) in combination with Norvir (ritonavir, from Abbott).” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 23, 2010 at 9:09 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA reviews cardiac risk of Invirase in combination with Norvir http://goo.gl/fb/DyEy
FDA reviews cardiac risk of Invirase in combination with Norvir - MPR
empr.com — “The FDA has notified healthcare professionals and patients that it is reviewing clinical trial data about a potentially serious effect on the heart associated with the use of Invirase (saquinavir, from Roche) in combination with Norvir (ritonavir, from Abbott).” View full resource at empr.com
Most Recently Shared on February 23, 2010 at 9:07 pm By:
MPR News: FDA reviews cardiac risk of Invirase in combination with Norvir: The FDA has notified healthcare profess... http://bit.ly/bNJGxD
Advertisement
